Medscape Newsfeed:
- Lymphoma: Dual-Targeting CAR T Shows Safety, Efficacy
KITE-363, a dual-targeting CAR T-cell therapy, shows a strong safety profile and high responses in patients who have highly refractory large B-cell lymphoma, new research shows. Medscape Medical News
- Thyroid Storm Deaths Rose With Covid-19, Other Risk Factors
A surge in thyroid storm deaths among those hospitalized with thyrotoxicosis was likely related to COVID-19, but other risk factors also played a role. Medscape Medical News
- DIF Microscopy Helps Diagnose Pediatric Skin Diseases
DIF microscopy provides diagnostic clarity in 15.5% of pediatric biopsies in a study. Medscape Medical News
- Add-On Simvastatin Shows No Benefit in Depression
Compared with placebo, simvastatin along with escitalopram fails to alleviate depressive symptoms in depression and obesity but improves the cardiometabolic risk profile, a trial shows. Medscape News UK
- Bone Inflammation Flags Pain Post-TFCC Surgery
An MRI-based study finds that bone marrow oedema predicts persistent pain after triangular fibrocartilage complex repair surgery, while scarring and effusions appear unrelated. Medscape News UK
NIH Newsfeed:
EM Journal Watch Newsfeed:
- Noninvasive Ventilation for Patients with Acute Asthma Exacerbations
A new systematic review suggests that NIV might benefit some patients.
- Does Prone Positioning Save Lives in Nonintubated Patients with COVID-19?
A meta-analysis offers compelling evidence that awake prone positioning improves outcomes in patients with acute hypoxemic respiratory failure.
- Interventions for Intermediate-Risk Pulmonary Embolism
Large-bore mechanical thrombectomy was superior to catheter-directed thrombolysis in a randomized trial.
- Intranasal Epinephrine Is Approved for Younger Children
1-mg “neffy” is now approved for children who weigh 15 to 30 kg.
- Cephalosporins for Outpatient Pyelonephritis?
The guidelines say no, but this study says OK.